01:42 PM EDT, 06/13/2024 (MT Newswires) -- BioRestorative Therapies ( BRTX ) rallied past 32% amid heavy trading after the company said Thursday it is in "substantive" licensing talks for its off-the-shelf metabolic intellectual property.

More than 86.6 million shares traded intraday versus a daily average of roughly 545,000.

Sharps Technology ( STSS ) said on Thursday that it received a signed $30 million purchase order from Nephron Pharmaceuticals, representing their first 12 months of syringe purchase commitments.

Shares rose 20% after intraday trading volume soared to more than 92.7 million versus the stock's daily average of about 8.7 million.

UroGen Pharma ( URGN ) on Thursday announced an "unprecedented" 82.3% duration of response at 12 months for UGN-102, or mitomycin, to treat patients with a type of bladder cancer.

Shares surged 42% as intraday trading volume advanced to over 5.3 million from a daily average of roughly 354,000.

Price: 1.77, Change: +0.43, Percent Change: +32.21